Connecting Science, Experts, and You

Curio Science™ facilitates expert-led, curiosity-driven scientific exchanges with healthcare providers (HCPs) across rapidly evolving therapeutic areas, including cancer and other serious diseases.

Curio Science™, a Vaniam Group company, provides HCPs the opportunity to participate in immersive, expert-led programs that are designed to generate real-time insights on practice patterns, the latest clinical data, and how these data are affecting decisions locally, regionally, and nationally. Subscribing companies from the pharmaceutical and biotech industry use these unbiased discussions to inform their clinical and commercial strategies and ultimately achieve the full potential of their pipelines and approved agents.

Established nearly a decade ago, Curio Science is the premier leader in facilitating scientific exchange and insights gathering within the healthcare industry. Leveraging real-time, comprehensive data, we empower the medical community and industry stakeholders with insights that drive science forward and continually push the boundaries of knowledge. Guided by the wisdom of our expert faculty, we generate an environment that nurtures continuous scientific exchange, enabling us to fulfill our promise to advance healthcare understanding and improve patient outcomes.

Together we are
shaping the future of
scientific exchange

How HCPs can participate
in our programs

Our programs provide a unique opportunity for expert faculty and other community- and university-based medical professionals to discuss current and emerging data and the potential impact on clinical practice. To learn more about joining our HCP network and receiving invitations to future programs, please contact

Get the most out of our comprehensive insights gathering with a Curio Science subscription tailored to fit your business goals. Our team is always available to help companies by answering questions, providing more information on the benefits of being a subscriber, and identifying programs that would offer the most impactful competitive insights. Please contact

How pharmaceutical
and biotech companies
can subscribe